• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6
Click for more information
12.2% $8.64

CLARITY PHARMACEUTICALS LTD

Market Cap $2.730B  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
Ann: Becoming a substantial holder 		20/09/24 40 7.7K
20/09/24 Last post  Hingdog Comments Created with Sketch.  40  Views Created with Sketch.  7.7K 
CU6
CU6 - ASX Charts
14 15 16
20/09/24 943 329K
20/09/24 Last post  Hingdog Comments Created with Sketch.  943  Views Created with Sketch.  329K 
CU6
CU6 - General discussion
6 7 8
20/09/24 475 167K
Metals & Mining SECTOR NEWS

Second round assay results shapes promising greenfields gold discovery at Claw Gold Project

Read More   right-arrow Created with Sketch.
BPM
20 Sep 2024
BPM MINERALS LIMITED
20/09/24 Last post  longreach Comments Created with Sketch.  475  Views Created with Sketch.  167K 
CU6
The Bear Room
2
20/09/24 72 22K
20/09/24 Last post  LongTony Comments Created with Sketch.  72  Views Created with Sketch.  22K 
CU6
Ann: Initial Director's Interest Notice - Parker 		20/09/24 0 242
20/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  242 
CU6
Ann: Appointment of Executive Director to Clarity's Board 		20/09/24 0 313
20/09/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  313 
CU6
Ann: Shareholder briefing - presentation
2
20/09/24 65 15K
20/09/24 Last post  Coit Comments Created with Sketch.  65  Views Created with Sketch.  15K 
CU6
CU6 - Media and Industry News
8 9 10
19/09/24 559 226K
19/09/24 Last post  ttppxx Comments Created with Sketch.  559  Views Created with Sketch.  226K 

See All Discussions arrow Created with Sketch.

Timeline

Initial Director's Interest Notice - Parker
20 Sep 14:48
 
Appointment of Executive Director to Clarity's Board
20 Sep 09:22
 
Becoming a substantial holder
20 Sep 08:19
 
Change of Director's Interest Notice - Robinson
18 Sep 16:04
 
Cleansing Notice
18 Sep 15:10
 
Application for quotation of securities - CU6
18 Sep 15:08
 
View More arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.

(20min delay)
Last
$8.64 		Change
0.940(12.2%) 		Mkt cap ! $2.730B
Open High Low Value Volume
$7.89 $8.81 $7.88 $217.9M 25.32M

Buyers (Bids)

No. Vol. Price($)
1 60 $8.55
 

Sellers (Offers)

Price($) Vol. No.
$8.65 196155 2
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
$8.49 		  Change
0.940 ( 10.9 %)
Open High Low Volume
$7.89 $8.83 $7.89 2673084
Last updated 15.59pm 20/09/2024 ?
CU6 (ASX) Chart

Top Stories

Auckland airport launches second round of equity raising, with $200M retail offer

Auckland International Airport Ltd is set to boost its coffers with a retail offer worth $200 million, which follows an earlier placement
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix 88 Energy has posted news of a "significant contingent resource update" for Project Phoenix – but HotCopper users weren't sure.
Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off Harvey Norman shares were up +0.62% to $4.85/sh heading into lunchtime in Sydney on Wednesday – even as Echo Law's class action kicks off.

Featured News

NEWS Positive results highlight gold and lithium potential at Shoobridge
right-arrow Created with Sketch.
NEWS Massive rare earth find near Jupiter project – high ratios of magnet oxides uncovered
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Highest-grade niobium assays uncovered at newly acquired Ecuador project – fast-tracking to production
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.